The Association for Diagnostics and Laboratory Medicine (ADLM) is actively advocating against the FDA’s recent regulation of laboratory-developed tests (LDTs), arguing that it will severely impact clinical laboratories’ ability to provide timely and specialized diagnostic services.
Follow this link to the ADLM website, where you can compose a message to your U.S. Senators and Representatives to express your concerns.
https://www.votervoice.net/BroadcastLinks/rbJgWfdCbFc6UB7eiVGjOQ